IRVINE, California, June 24 -- The University of California Irvine campus issued the following news release:

* * *

First patient receives neural stem cell therapy in groundbreaking UCI Health Huntington's disease clinical trial

World's first neural stem cell phase 1b/2a clinical trial for condition leverages innovative technology

* Huntington's disease is a genetic disorder that gradually destroys brain cells over the course of 1 . . .

Click here for more information about our products